Fulgent Genetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	289.21	618.97	992.58	421.71	32.53	21.35	18.73	18.28	9.58	1.28
Revenue Growth (YoY)	-53.27%	-37.64%	135.37%	1196.46%	52.35%	13.99%	2.48%	90.85%	649.30%	-
Cost of Revenue	184.76	252.07	215.53	89.81	14.11	10.7	8.55	6.72	5.07	0.94
Gross Profit	104.46	366.9	777.05	331.91	18.42	10.65	10.18	11.55	4.51	0.34
Selling, General & Admin	130.47	149.99	75.17	30.17	12.31	10.19	9.44	7.08	5.09	0.81
Research & Development	41.44	28.91	24.22	11.58	6.54	5.53	4.22	3.56	4.43	0.52
Other Operating Expenses	128.08	9.47	1.71	0	0	0	0	0	0	0
Operating Expenses	299.99	188.37	101.1	41.75	18.85	15.72	13.66	10.64	9.52	1.33
Operating Income	-195.53	178.53	675.95	290.16	-0.43	-5.07	-3.48	0.92	-5.01	-0.99
Interest Expense / Income	0	0	0	0	0	0	0	5.39	-0.03	0
Other Expense / Income	-28.86	-6.98	-6.21	3.32	-0.06	0.5	0.04	-0.04	3.33	3.29
Pretax Income	-166.67	185.51	682.16	286.84	-0.37	-5.57	-3.53	-4.43	-8.31	-4.28
Income Tax	1.15	42.1	174.8	72.53	0.04	0.04	-1.02	0.92	0	0
Net Income	-167.83	143.4	507.36	214.31	-0.41	-5.61	-2.51	-5.35	-8.31	-4.28
Net Income Growth	-	-71.74%	136.74%	-	-	-	-	-	-	-
Shares Outstanding (Basic)	30	30	29	23	19	18	18	14	12	-
Shares Outstanding (Diluted)	30	31	31	24	19	18	18	14	12	-
Shares Change	-3.81%	-0.04%	28.77%	28.58%	4.07%	1.35%	29.39%	15.77%	-	-
EPS (Basic)	-5.63	4.76	17.25	9.44	-0.02	-0.31	-0.14	-1.00	-0.61	-
EPS (Diluted)	-5.63	4.63	16.38	8.91	-0.02	-0.31	-0.14	-1.00	-0.61	-
EPS Growth	-	-71.73%	83.84%	-	-	-	-	-	-	-
Free Cash Flow	5.57	235.16	514.83	105.51	4.34	-3.51	-4.03	0.63	-3	-5.13
Free Cash Flow Per Share	0.19	7.81	17.51	4.65	0.23	-0.20	-0.23	0.05	-0.25	-
Gross Margin	36.12%	59.28%	78.29%	78.70%	56.63%	49.90%	54.35%	63.22%	47.07%	26.76%
Operating Margin	-67.61%	28.84%	68.10%	68.80%	-1.32%	-23.75%	-18.59%	5.02%	-52.34%	-77.46%
Profit Margin	-58.03%	23.17%	51.12%	50.82%	-1.26%	-26.26%	-13.40%	-29.26%	-86.82%	-335.13%
Free Cash Flow Margin	1.93%	37.99%	51.87%	25.02%	13.33%	-16.43%	-21.49%	3.43%	-31.32%	-401.25%
Effective Tax Rate	-	22.70%	25.62%	25.29%	-	-	-	-	-	-
EBITDA	-134.12	223.08	694.32	290.21	2.15	-3.41	-1.8	2.13	-7.77	-4.09
EBITDA Margin	-46.37%	36.04%	69.95%	68.82%	6.62%	-15.96%	-9.59%	11.65%	-81.10%	-319.80%
Depreciation & Amortization	32.56	37.58	12.16	3.37	2.52	2.16	1.73	1.17	0.58	0.2
EBIT	-166.67	185.51	682.16	286.84	-0.37	-5.57	-3.53	0.96	-8.34	-4.28
EBIT Margin	-57.63%	29.97%	68.73%	68.02%	-1.13%	-26.09%	-18.82%	5.25%	-87.10%	-335.13%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).